Entertainment

Blessing CEO Apologises to Nigerians Amid Health Controversy, Promises Medical Transparency

Share
Share

Controversial relationship expert Blessing CEO has issued a public apology to Nigerians following widespread criticism over the controversy surrounding her health condition and alleged cancer claims.

The development comes after reports that she had solicited financial assistance from the public, claiming to be battling stage 4 cancer. The situation sparked intense debate online, with many questioning the accuracy of her claims and how donations were solicited.

In a video shared on her Instagram page, Blessing CEO expressed regret over the confusion and backlash generated by the situation. She apologised to her supporters, fans, and the Nigerian public, describing the controversy as unnecessary and embarrassing.

She, however, maintained that she did not deliberately mislead anyone about her health status. According to her, she intends to provide full medical documentation, including scan results and biopsy reports, as part of efforts to clarify her condition and keep the public informed.

  Blord Speaks After Release from Kuje Prison, Thanks Supporters and Activists

Blessing CEO added that she would continue documenting her health journey publicly, similar to how she previously shared personal medical procedures.

She also addressed those who contributed financially, stating that anyone who requests a refund will be attended to upon submission of proof of payment and bank details.

Her statement read in part that she was sorry for the confusion and promised greater transparency moving forward, while thanking supporters who stood by her during the controversy.

The situation has continued to generate mixed reactions across social media, with debates ongoing about influencer accountability, online fundraising, and the boundaries between personal health disclosure and public engagement.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *